A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
<p>Abstract</p> <p>Background</p> <p>Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the treatment of rheumatoid arthritis (RA).</p> <p>Methods</p> <p>Double-blind, randomized, placebo and active comparator-controlled, 12...
Main Authors: | Zhao Peng, Melian Agustin, McCarthy Timothy, Casas Noemi, Lee Ka Wing, Curtis Sean P, Collantes Eduardo, Rodgers Diana, McCormick Calogera, Lee Michael, Lines Christopher, Gertz Barry |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-05-01
|
Series: | BMC Family Practice |
Online Access: | http://www.biomedcentral.com/1471-2296/3/10 |
Similar Items
-
Comparative evaluation of the safety and efficacy of etoricoxib and diclofenac on the upper gastrointestinal tract in patients with osteoarthrosis and rheumatoid arthritis (the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program)
by: L I Alekseyeva
Published: (2010-08-01) -
ETORICOXIB: THERAPEUTIC POTENTIAL
by: A. E. Karateev
Published: (2009-03-01) -
Etoricoxib in the treatment of osteoarthritis
by: S. G. Anikin, et al.
Published: (2020-03-01) -
Etoricoxib (arcoxia) in rheumatology
by: Fatima Magomedovna Kudaeva, et al.
Published: (2011-06-01) -
Cardiovascular safety of etoricoxib
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01)